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S U M M A R Y 
The study evaluated the non-adherence to selected cardiovascular medications, 
atenolol, atorvastatin, bisoprolol, diltiazem, lisinopril, simvastatin and valsartan in 
Iraqi patients by applying a standardized Morisky questionnaire (8-MMAS) and by 
measuring therapeutic drug concentrations in dried blood spots (DBS) analysed by 
liquid chromatography - high resolution mass spectrometry (LC-HRMS). Sixty-
nine patients on continued use of one or more of the selected drugs were 
evaluated. The questionnaire showed that 21.7% of participants were non-adherent 
whereas DBS analysis showed that 49.3% were non-adherent to their medications. 
No significant correlation between medication non-adherence and gender was 
detected, but adherence was negatively correlated with the number of medication 
in the regimen. The 8-items questionnaire was unable to differentiate non-
adherence to multi-medications in the prescribed pharmacotherapy regimens. DBS 
is an alternative to conventional methods to monitor non-adherence objectively. 
Agreement between the two approaches was weak (Kappa =0.269, p- value 0.05).
INTRODUCTION 
Cardiovascular disease (CVD) is a broad term 
covering disorders of the heart and blood vessels. 
Examples include hypertension, angina, heart attack, 
stroke, and heart failure [1]. CVDs accounts for the 
highest number of deaths worldwide [2]. There is 
evidence that as many as 50% of prescribed CVD 
drugs worldwide are not taken by patients as 
recommended. Medication adherence can be 
assessed by indirect methods (e.g. questionnaire) or 
direct methods (concentration of drugs or 
metabolites in a biological fluid (such as urine or 
blood). However, no consensus has been reached on 
a gold standard for routine clinical practice [3]. 
The 8-item Morisky Medication Adherence Scale (8-
MMAS), provides a single qualitative ternary metric  
 
to assess adherence (low, medium, or high) 
depending on the total score. Conventional direct 
methods require large blood volumes (0.5 – 10 mL) 
[1]. Dried blood spot (DBS) sampling is an alternative 
to conventional methods [4]. It is less invasive, 
typically involving the collection of just a few drops 
of blood from a finger or heel prick onto a filter 
paper [1]. The aim of this research was to assess 
patients’ non-adherence to treatment with atenolol, 
atorvastatin, bisoprolol, diltiazem, lisinopril, 
losartan, simvastatin and valsartan by 8-MMAS and 
determination of the target medications in DBS from 
the same patients and to compare the results 
obtained from the two approaches 
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MATERIALS AND METHODS 
69 patients were recruited at the Alsaeder Teaching 
Hospital in Iraq during routine clinical visits. 
Following consent, patients were invited to complete 
an Arabic version of (8-MMAS) questionnaire and to 
provide a finger-prick blood spots samples on DBS 
cards. Drugs concentration in DBS was determined 
by liquid chromatography-high resolution mass 
spectrometry (LC-HRMS)[5]. Patients were 
categorized as non-adherent when one or more of 
their prescribed cardiovascular medications were 
outside the range of (0.05) Cmax to Cmax. 
RESULTS AND DISCUSSION 
8-MMAS showed that 54 participants (78.3%) were 
adherent (30 males and 24 females), 15 participants 
(21.7%) were non-adherent ( 11 males and 4 females). 
However, adherence assessment by DBS showed that 
35 patients (50.7%) were adherent to medications (21 
males and 14 females) and 34 patients (49.3%) were 
non-adherent (20 males and 14 females). Both 
approaches showed no significant relationship 
between medication non-adherence and gender.  The 
negative correlation between adherence and the 
number of medications was seen in both approaches. 
DBS analysis showed that adherence to medication 
was not uniform (Fig 1). 44 participants (63.8%) 
showed agreement and 25 (36.2%) showed 
disagreement. 22 patients were classified as adherent 
according to 8-MMAS but they were non-adherent 
according to their blood concentration. This 
difference may be due to prescribing errors, 
substandard medications, individual 
pharmacokinetic variability, or drug interactions. 
The other 3 patients were non-adherent by the 8-
MMAS but were defined as adherent according to 
DBS analysis. The agreement between the two 
approached was weak (Kappa = 0.269, p-value ˂ 
0.05).  
The answers to the Morisky questions with respect to 
non-adherence were: 
• 75% cited inconvenience with medications  
• 70.7% gave no reasons 
• 66.7% cited medication side effects 
• 58.3% cited poor understanding of treatment 
• 58.3% cited travel problem  
• 41.7% cited simple forgetfulness   
Fig. 1. Comparison of non-adherence among the Iraq 
patient group for each of the target cardiovascular drugs 
by DBS analysis and 8-MMAS 
CONCLUSIONS 
The Morisky 8-MMAS and the DBS sampling 
approach both indicated levels of non-adherence. 
Poor agreement between the two approaches was 
seen. The DBS derived data provided drug specific 
information about patient medication taking 
behaviour. The results from the DBS sampling 
indicated that non-adherence was not uniform 
towards the different medications in the sample 
medical regimens tested.  
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